HABA Laboratories,Inc. (TYO:4925)

HABA Laboratories,Inc. Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	5,146	5,784	4,743	3,959	4,817	5,651
Cash & Short-Term Investments	5,146	5,784	4,743	3,959	4,817	5,651
Cash Growth	14.94%	21.95%	19.80%	-17.81%	-14.76%	-0.21%
Receivables	902	1,253	1,196	1,259	975	1,126
Inventory	2,614	2,570	2,921	3,713	3,368	3,151
Other Current Assets	237	173	175	145	183	143
Total Current Assets	8,899	9,780	9,035	9,076	9,343	10,071
Property, Plant & Equipment	2,372	2,374	2,969	2,955	4,452	4,655
Long-Term Investments	171	177	187	315	308	377
Other Intangible Assets	127	112	93	-	315	346
Long-Term Deferred Tax Assets	88	74	58	83	235	234
Other Long-Term Assets	1	2	2	2	2	2
Total Assets	11,658	12,519	12,344	12,431	14,655	15,685

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	339	323	236	303	475	336
Short-Term Debt	-	100	500	600	200	300
Current Portion of Long-Term Debt	464	480	589	754	801	785
Current Income Taxes Payable	627	913	943	701	869	792
Other Current Liabilities	357	530	390	455	453	318
Total Current Liabilities	1,787	2,346	2,658	2,813	2,798	2,531
Long-Term Debt	494	607	727	1,000	1,031	1,472
Long-Term Deferred Tax Liabilities	-	-	2	50	-	-
Other Long-Term Liabilities	31	30	30	62	54	46
Total Liabilities	2,312	2,983	3,417	3,925	3,883	4,049

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	696	696	696	696	696	696
Additional Paid-In Capital	812	812	812	812	812	812
Retained Earnings	8,973	9,163	8,554	8,128	10,398	11,257
Treasury Stock	-1,136	-1,136	-1,136	-1,135	-1,135	-1,135
Comprehensive Income & Other	1	1	1	5	1	6
Shareholders' Equity	9,346	9,536	8,927	8,506	10,772	11,636
Total Liabilities & Equity	11,658	12,519	12,344	12,431	14,655	15,685

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	958	1,187	1,816	2,354	2,032	2,557
Net Cash (Debt)	4,188	4,597	2,927	1,605	2,785	3,094
Net Cash Growth	43.62%	57.05%	82.37%	-42.37%	-9.99%	77.31%
Net Cash Per Share	1107.50	1215.66	774.03	424.43	736.48	818.18
Filing Date Shares Outstanding	3.78	3.78	3.78	3.78	3.78	3.78
Total Common Shares Outstanding	3.78	3.78	3.78	3.78	3.78	3.78
Working Capital	7,112	7,434	6,377	6,263	6,545	7,540
Book Value Per Share	2471.52	2521.76	2360.72	2249.36	2848.59	3077.07
Tangible Book Value	9,219	9,424	8,834	8,506	10,457	11,290
Tangible Book Value Per Share	2437.93	2492.15	2336.12	2249.36	2765.29	2985.57

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error